HUGE study to compare tamoxifen and raloxifene for preventing breast cancer
July 1999
Researchers are now starting a HUGE study to compare tamoxifen and raloxifene for preventing breast cancer.
It's called STAR..."Study of Tamoxifen And Raloxifene."
Tamoxifen (Nolvadex) reduces the risk of breast cancer by almost 50% in high-risk women.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote